VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASCO 2020 | Highlights in multiple myeloma at ASCO 2020

Suzanne Lentzsch • 29 May 2020
ASCO 2020
Multiple Myeloma
BOSTON GMMG-CONCEPT KarMMa StaMINA SWOG 1211

Suzanne Lentzsch, MD, PhD, Columbia University, New York, NY, USA, takes us through a selection of the most important studies presented at ASCO 2020 in multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Suzanne Lentzsch

2:55
Chemotherapy-free approaches to AL amyloidosis
Suzanne Lentzsch • 27 Aug 2020
2:38
How to treat AL amyloidosis in 2020?
Suzanne Lentzsch • 31 Aug 2020
3:21
IMiDs induce hematopoietic malignancies
Suzanne Lentzsch • 12 Sep 2018
4:07
The potential of anti-amyloid antibodies to treat amyloidosis
Suzanne Lentzsch • 12 Sep 2018

Related Videos

4:28
A.R.R.O.W. study: carfilzomib dosing in frail MM patients
Maria-Victoria Mateos
1:16
Managing CRS in myeloma
Nina Shah
2:26
Managing transplant patients during the COVID-19 pandemic
Christian Chabannon
3:43
DNA methyltransferase inhibitors: daratumumab enhancement for MM
Priya Choudhry
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals